Brooks Laboratories Ltd.
BSE: 533543 | Sector: Health care |
NSE: BROOKS | ISIN Code: INE650L01011 |
BSE 10:09 | 25 Feb | 60.50 |
-0.20 (-0.33%) |
OPEN
60.60 |
HIGH
61.00 |
LOW
60.05 |
NSE 10:07 | 25 Feb | 60.10 |
0.10 (0.17%) |
OPEN
61.40 |
HIGH
61.40 |
LOW
59.25 |
OPEN | 60.60 |
PREVIOUS CLOSE | 60.70 |
VOLUME | 201 |
52-Week high | 77.70 |
52-Week low | 14.05 |
P/E | |
Mkt Cap.(Rs cr) | 149 |
Buy Price | 59.75 |
Buy Qty | 2.00 |
Sell Price | 60.20 |
Sell Qty | 133.00 |
Brooks Laboratories Ltd. (BROOKS) - Announcements
-
Brooks Laboratories Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
17/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
17/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
17/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
12/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Modification In The Clause Of Code Of Practices And Procedures For Fair Disclosure Of Unpublished Pr
11/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Unaudited Financial Results For The Quarter Ended 31.12.2020
11/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
03/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Board Meeting Intimation for Inter Alia Approval Of Unaudited Financial Results For The 3Rd Quarter
02/02/2021 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
12/01/2021 | bse
-
Brooks Laboratories Ltd Shareholding for the Period Ended December 31 2020
11/01/2021 | bse
-
Brooks Laboratories Ltd Closure of Trading Window
29/12/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Related Party Transaction For The Half Yearly Ended 30.09.2020
09/12/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Typographical Error In Unaudited Financial Results For 2Nd Quarter Ended 30.09.2020
13/11/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
13/11/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Unaudited Financial Results For Half Year Ended 30.09.2020
13/11/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
05/11/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Board Meeting Intimation for Approval Of Unaudited Financial Results For The 2Nd Quarter Ended 30.09
04/11/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd PCS Certificate Under Regulation 40(9) Of SEBI(LODR) Regulations 2015
21/10/2020 | bse |
Downlaod PDF
-
Brooks Laboratories Ltd Shareholding for the Period Ended September 30 2020
21/10/2020 | bse
-
Brooks Laboratories Ltd Compliance Certificate Under Reg 7(3) Of SEBI(LODR) Regulations 2015.
15/10/2020 | bse |
Downlaod PDF
Quick Links for Brooks Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices